220 related articles for article (PubMed ID: 26759307)
1. Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma.
Lee AY; Agaram NP; Qin LX; Kuk D; Curtin C; Brennan MF; Singer S
Ann Surg Oncol; 2016 Mar; 23(3):818-25. PubMed ID: 26759307
[TBL] [Abstract][Full Text] [Related]
2. Comparative Study of Myxofibrosarcoma With Undifferentiated Pleomorphic Sarcoma: Histopathologic and Clinicopathologic Review.
Yoshimoto M; Yamada Y; Ishihara S; Kohashi K; Toda Y; Ito Y; Yamamoto H; Furue M; Nakashima Y; Oda Y
Am J Surg Pathol; 2020 Jan; 44(1):87-97. PubMed ID: 31651522
[TBL] [Abstract][Full Text] [Related]
3. Patterns of disease relapse in primary extremity soft-tissue sarcoma.
Smith HG; Memos N; Thomas JM; Smith MJ; Strauss DC; Hayes AJ
Br J Surg; 2016 Oct; 103(11):1487-96. PubMed ID: 27503444
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.
Cipriani NA; Kurzawa P; Ahmad RA; Deshpande V; Hornicek FJ; Mullen JT; Nielsen GP
Hum Pathol; 2014 Jul; 45(7):1504-8. PubMed ID: 24780826
[TBL] [Abstract][Full Text] [Related]
5. Surgical margins do not affect prognosis in high grade myxofibrosarcoma.
Sambri A; Bianchi G; Righi A; Ferrari C; Donati D
Eur J Surg Oncol; 2016 Jul; 42(7):1042-8. PubMed ID: 27260849
[TBL] [Abstract][Full Text] [Related]
6. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems.
Huang HY; Lal P; Qin J; Brennan MF; Antonescu CR
Hum Pathol; 2004 May; 35(5):612-21. PubMed ID: 15138937
[TBL] [Abstract][Full Text] [Related]
7. Biology, classification, and management of recurrent myxofibrosarcoma 21 years after resection.
Palumbo BT; Henderson E; Letson GD; Cheong D
Am J Orthop (Belle Mead NJ); 2011 Nov; 40(11):579-82. PubMed ID: 22263212
[TBL] [Abstract][Full Text] [Related]
8. Chondroitin sulfate synthase 1 expression is associated with malignant potential of soft tissue sarcomas with myxoid substance.
Momose T; Yoshimura Y; Harumiya S; Isobe K; Kito M; Fukushima M; Kato H; Nakayama J
Hum Pathol; 2016 Apr; 50():15-23. PubMed ID: 26997434
[TBL] [Abstract][Full Text] [Related]
9. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk.
Dalal KM; Kattan MW; Antonescu CR; Brennan MF; Singer S
Ann Surg; 2006 Sep; 244(3):381-91. PubMed ID: 16926564
[TBL] [Abstract][Full Text] [Related]
10. Does pre-operative MRI predict the risk of local recurrence in primary myxofibrosarcoma of the extremities?
Sambri A; Spinnato P; Bazzocchi A; Tuzzato GM; Donati D; Bianchi G
Asia Pac J Clin Oncol; 2019 Oct; 15(5):e181-e186. PubMed ID: 31111597
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.
Roland CL; May CD; Watson KL; Al Sannaa GA; Dineen SP; Feig R; Landers S; Ingram DR; Wang WL; Guadagnolo BA; Feig B; Hunt KK; Cormier JN; Lazar AJ; Torres KE
Ann Surg Oncol; 2016 Jul; 23(7):2220-8. PubMed ID: 26847678
[TBL] [Abstract][Full Text] [Related]
12. Natural history of undifferentiated pleomorphic sarcoma: Experience from the US Sarcoma Collaborative.
Makris EA; Tran TB; Delitto DJ; Lee B; Ethun CG; Grignol V; Harrison Howard J; Bedi M; Clark Gamblin T; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Cullinan D; Fields RC; Cardona K; Poultsides G; Kirane A
J Surg Oncol; 2024 Jun; 129(7):1354-1363. PubMed ID: 38562002
[TBL] [Abstract][Full Text] [Related]
13. Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions.
Dineen SP; Roland CL; Feig R; May C; Zhou S; Demicco E; Sannaa GA; Ingram D; Wang WL; Ravi V; Guadagnolo A; Lev D; Pollock RE; Hunt K; Cormier J; Lazar A; Feig B; Torres KE
Ann Surg Oncol; 2015 Nov; 22(12):3913-20. PubMed ID: 25743327
[TBL] [Abstract][Full Text] [Related]
14. Systematic screening identifies a 2-gene signature as a high-potential prognostic marker of undifferentiated pleomorphic sarcoma/myxofibrosarcoma.
Hu Q; Zhou S; Hu X; Zhang H; Huang S; Wang Y
J Cell Mol Med; 2020 Jan; 24(1):1010-1021. PubMed ID: 31742892
[TBL] [Abstract][Full Text] [Related]
15. Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma.
Tan MC; Brennan MF; Kuk D; Agaram NP; Antonescu CR; Qin LX; Moraco N; Crago AM; Singer S
Ann Surg; 2016 Mar; 263(3):593-600. PubMed ID: 25915910
[TBL] [Abstract][Full Text] [Related]
16. Cytopathology of myxofibrosarcoma: a study of 66 cases and literature review.
Wakely PE
J Am Soc Cytopathol; 2021; 10(3):300-309. PubMed ID: 33041221
[TBL] [Abstract][Full Text] [Related]
17. Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.
Fiore M; Grosso F; Lo Vullo S; Pennacchioli E; Stacchiotti S; Ferrari A; Collini P; Lozza L; Mariani L; Casali PG; Gronchi A
Cancer; 2007 Jun; 109(12):2522-31. PubMed ID: 17510918
[TBL] [Abstract][Full Text] [Related]
18. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance.
Massi D; Beltrami G; Capanna R; Franchi A
Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563
[TBL] [Abstract][Full Text] [Related]
19. Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables.
Stojadinovic A; Leung DH; Allen P; Lewis JJ; Jaques DP; Brennan MF
J Clin Oncol; 2002 Nov; 20(21):4344-52. PubMed ID: 12409334
[TBL] [Abstract][Full Text] [Related]
20. An analysis of factors related to recurrence of myxofibrosarcoma.
Kikuta K; Kubota D; Yoshida A; Suzuki Y; Morioka H; Toyama Y; Kobayashi E; Nakatani F; Chuuman H; Kawai A
Jpn J Clin Oncol; 2013 Nov; 43(11):1093-104. PubMed ID: 23969617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
